3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
3
Sarcoma
2
Genitourinary
2
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Wilms Tumor
1
Unspecified Childhood Solid Tumor, Protocol Specific
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Retinoblastoma
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive
1
Medulloblastoma
1
Glioma
1
Interventions
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Etoposide
4
Busulfan
4
Thiotepa
3
Melphalan
3
Ifosfamide
3
Carboplatin
3
Peripheral Blood Stem Cell Transplantation
2
Mesna
2
sargramostim
1
omburtamab I-131
1
etoposide phosphate
1
entinostat
1
becatecarin
1
alvocidib
1
Ursodeoxycholic Acid
1
Thrombopoietin
1
Thalidomide
1
Tamoxifen
1
Stem Cell Transplantation
1
Sirolimus
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiation
1
Paclitaxel
1
Leukapheresis
1
LY2940680
1
Immunologic Techniques
1
Fentanyl
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Medulloblastoma
×
Thalidomide
×
Other solid neoplasm
×
Clear all
NCT01661400
2024-01-31
ASCR
Washington University School of Medicine
Phase 1
Completed
14 enrolled